Page last updated: 2024-10-24

celecoxib and Pyogenic Sacroiliitis

celecoxib has been researched along with Pyogenic Sacroiliitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"To analyze the changes in the levels of bone metabolism markers related to sacroiliac joint (SIJ) inflammation in patients with axial spondyloarthritis (axSpA) after treatment with imrecoxib and celecoxib and evaluate their relationship with clinical efficacy."8.31Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis. ( Chen, Y; Gao, G; Guo, Y; Jiang, D; Li, T; Mai, Z, 2023)
"To analyze the changes in the levels of bone metabolism markers related to sacroiliac joint (SIJ) inflammation in patients with axial spondyloarthritis (axSpA) after treatment with imrecoxib and celecoxib and evaluate their relationship with clinical efficacy."4.31Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis. ( Chen, Y; Gao, G; Guo, Y; Jiang, D; Li, T; Mai, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, Y1
Jiang, D1
Mai, Z1
Chen, Y1
Li, T1
Gao, G1

Other Studies

1 other study available for celecoxib and Pyogenic Sacroiliitis

ArticleYear
Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis.
    Clinical rheumatology, 2023, Volume: 42, Issue:6

    Topics: Axial Spondyloarthritis; beta Catenin; Celecoxib; Core Binding Factor Alpha 1 Subunit; Humans; Infla

2023